Early therapeutic interventions in inflammatory rheumatic diseases have proven successful in inducing drug-free remission, and EULAR...

Neoadjuvant immunotherapy given for stage III melanoma, followed by adjuvant therapy only if there is not...

Osimertinib improves PFS in patients with unresectable stage III EGFR-mutated non-small cell lung cancer (NSCLC)...

The antibody-drug conjugate trastuzumab deruxtecan delays cancer growth for women with hormone receptor-positive (HR+)...

According to a new study presented at the 2024 ASCO Annual Meeting, adding the antibody-drug conjugate...

For patients with locally advanced oesophageal adenocarcinoma that can be treated with surgery, chemotherapy treatment...

Results from a new study presented at the 2024 American Society of Clinical Oncology (ASCO) Annual...

The management of bladder cancer is evolving rapidly, with a new regimen recently approved for patients...

Interferon seems to raise migraine risk in people with MS, while rituximab may lower it. A...

The American Headache Society recently issued a position statement update on the use of migraine prevention...

An overview of the latest insights, diagnostic criteria, and treatment approaches for migraines. Migraine is the...